Sarepta Therapeutics, Inc. SRPT Interest Paid, Excluding Capitalized Interest, Operating Activity
Interest Paid, Excluding Capitalized Interest, Operating Activity at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s interest paid, excluding capitalized interest, operating activity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s interest paid, excluding capitalized interest, operating activity?
- Sarepta Therapeutics, Inc. (SRPT) reported interest paid, excluding capitalized interest, operating activity of $23.42M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s interest paid, excluding capitalized interest, operating activity changed year-over-year?
- Sarepta Therapeutics, Inc.'s interest paid, excluding capitalized interest, operating activity increased by 225.8% year-over-year, from $7.19M to $23.42M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s interest paid, excluding capitalized interest, operating activity?
- Over 4 years (2021 to 2025), Sarepta Therapeutics, Inc.'s interest paid, excluding capitalized interest, operating activity has grown at a -28.1% compound annual growth rate (CAGR), from $55.95M to $14.91M.